Cardiovascular Toxicology is the only journal dedicated to publishing contemporary issues, timely reviews, and experimental and clinical data on the molecular therapy of cardiovascular disease. CT publishes papers that will elucidate the effects, molecular mechanisms, and signaling pathways of environmental toxicants on the cardiovascular system. Also covered are the detrimental effects of new cardiovascular drugs, and cardiovascular effects of non-cardiovascular drugs, anti-cancer chemotherapy, and gene therapy. In addition, Cardiovascular Toxicology reports safety and toxicological data on new cardiovascular and non-cardiovascular drugs. This is a unique journal in which these data can be scrutinized separately from efficacy.
This is a transformative journal, you may have access to funding.
Part 1: Special Section on Call for Papers: Impact of Metal Exposures on Cardiovascular including Cardiometabolic Diseases: Pre-clinical models, Mechanistic Insights, Clinical Applications (first 2 articles) Part 2: Regular Papers (last 7 articles)
Through this Special Issue, we aspire to bring together bring epidemiologists, clinicians, translational, and molecular toxicologists together to explore the role of occupational and environmental exposure to heavy metals through direct toxicity and indirect effects by disturbing homeostatic mechanisms regulating essential metals, as well systemic parameters including lipid levels and blood pressure, etc... We seek data linking multiple different metals to CVD/metabolic disease to define differences and commonalities between outcomes associated with metal exposures. We believe that all these discussions will accelerate the development of efficient prevention and therapeutic strategies necessary to prevent epidemic of cardiometabolic disease.
Dr. Daniel J. Conklin will take over the role of Editor-in-Chief (EiC) of Cardiovascular Toxicology (CATO), starting from April 2023.
With Dan’s onboarding, I’m confident we’ll start another excellent chapter for CATO. Please join us in welcoming Dan as the new EiC.
Cardiovascular Toxicology was launched in 2001, and has been produced regularly for 20 years. It started 4 issues/year until 2018, expanding to 6 issues/year. It is now ready to expand again to 12 issues/year starting 2021.
© Springer Science+Business Media, LLC, part of Springer Nature